Literature DB >> 21085049

Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching.

William P Hanage1, Cynthia J Bishop, Susan S Huang, Abbie E Stevenson, Stephen I Pelton, Marc Lipsitch, Jonathan A Finkelstein.   

Abstract

BACKGROUND: Vaccination against 7 serotypes of Streptococcus pneumoniae has led to the near extinction of vaccine serotypes in both disease and asymptomatic carriage. In carriage, vaccine serotypes have been replaced by nonvaccine serotypes.
METHODS: We used multilocus sequence typing to analyze a sample of 294 isolates of S. pneumoniae carried by Massachusetts children (aged, 3 months-7 years) and examine the results for serotype switching and association with antimicrobial resistance.
RESULTS: Eighty-six distinct sequence types (STs) were found, 10 of which exhibited a serotype other than that which would be expected from previous carriage samples. We interpret this as evidence of past or recent serotype switching. Switched variants include ST 320, which is a common and increasing source of multidrug resistance in this community. Switching events within serogroups were more common than expected by chance (P = 0.043 by a Monte Carlo approach). Using multilocus sequence typing data and eBURST analysis, we also describe clonal dynamics within the important replacement serotypes 19A, 15B/C, 35B, and the recently described 6C.
CONCLUSIONS: Some strains generated by serotype switching are increasingly important parts of the carriage population. In the case of 19A, it appears that the majority of increase is due to ST 320, a recently reported switched variant. This may have consequences for the STs causing invasive pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21085049      PMCID: PMC3175614          DOI: 10.1097/INF.0b013e318201a154

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  27 in total

Review 1.  Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.

Authors:  Melvin P Weinstein; Keith P Klugman; Ronald N Jones
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

2.  Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.

Authors:  Didrik F Vestrheim; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

3.  Continued impact of pneumococcal conjugate vaccine on carriage in young children.

Authors:  Susan S Huang; Virginia L Hinrichsen; Abbie E Stevenson; Sheryl L Rifas-Shiman; Ken Kleinman; Stephen I Pelton; Marc Lipsitch; William P Hanage; Grace M Lee; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

4.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

5.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

6.  Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

Authors:  R Sá-Leão; S Nunes; A Brito-Avô; N Frazão; A S Simões; M I Crisóstomo; A C S Paulo; J Saldanha; I Santos-Sanches; H de Lencastre
Journal:  Clin Microbiol Infect       Date:  2009-04-23       Impact factor: 8.067

7.  Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Authors:  Matthew R Moore; Robert E Gertz; Robyn L Woodbury; Genevieve A Barkocy-Gallagher; William Schaffner; Catherine Lexau; Kenneth Gershman; Arthur Reingold; Monica Farley; Lee H Harrison; James L Hadler; Nancy M Bennett; Ann R Thomas; Lesley McGee; Tamara Pilishvili; Angela B Brueggemann; Cynthia G Whitney; James H Jorgensen; Bernard Beall
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

8.  Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.

Authors:  Sandra S Richter; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Susan E Beekmann; Gary V Doern
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

9.  Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction.

Authors:  Robert E Gertz; M Catherine McEllistrem; David J Boxrud; Zhongya Li; Varja Sakota; Terry A Thompson; Richard R Facklam; John M Besser; Lee H Harrison; Cynthia G Whitney; Bernard Beall
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Identification of the major Spanish clones of penicillin-resistant pneumococci via the Internet using multilocus sequence typing.

Authors:  J Zhou; M C Enright; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

View more
  35 in total

1.  Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal.

Authors:  Alexandra S Simões; Liliana Pereira; Sónia Nunes; António Brito-Avô; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Correlates of Nonrandom Patterns of Serotype Switching in Pneumococcus.

Authors:  Shreyas S Joshi; Mohammad A Al-Mamun; Daniel M Weinberger
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

3.  Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.

Authors:  W P Hanage; C J Bishop; G M Lee; M Lipsitch; A Stevenson; S L Rifas-Shiman; S I Pelton; S S Huang; J A Finkelstein
Journal:  Vaccine       Date:  2011-09-29       Impact factor: 3.641

4.  Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.

Authors:  Peter C Wroe; Grace M Lee; Jonathan A Finkelstein; Stephen I Pelton; William P Hanage; Marc Lipsitch; Abbie E Stevenson; Sheryl L Rifas-Shiman; Ken Kleinman; M Maya Dutta-Linn; Virginia L Hinrichsen; Matthew Lakoma; Susan S Huang
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

Review 5.  Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.

Authors:  M Catherine McEllistrem; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2012-08-16       Impact factor: 9.079

6.  Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York.

Authors:  Janet R Casey; Ravinder Kaur; Victoria C Friedel; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

7.  Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2016-08       Impact factor: 2.129

8.  Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period.

Authors:  Grace M Lee; Ken Kleinman; Stephen Pelton; Marc Lipsitch; Susan S Huang; Matt Lakoma; Maya Dutta-Linn; Melisa Rett; William P Hanage; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2017-10-04       Impact factor: 7.124

9.  A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella.

Authors:  B A Evans; D E Rozen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

10.  Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.

Authors:  Ioanna N Grivea; Alexia Sourla; Eleni Ntokou; Denise C Chryssanthopoulou; Alexandra G Tsantouli; George A Syrogiannopoulos
Journal:  BMC Infect Dis       Date:  2012-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.